Helfgott, David C

Publications

Sort by

Co-Author Network

Phase 3 pharmacokinetics and safety study of a posaconazole tablet formulation in patients at risk for invasive fungal disease. The Journal of antimicrobial chemotherapy. 2015 Academic Article GET IT
Times cited: 150
Phase 1b study of new posaconazole tablet for prevention of invasive fungal infections in high-risk patients with neutropenia. Antimicrobial agents and chemotherapy. 2014 Academic Article GET IT
Times cited: 101
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies. Leukemia & lymphoma. 2012 Academic Article GET IT
Times cited: 86
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. The New England journal of medicine. 2007 Academic Article GET IT
Times cited: 1292
Role and effect of TNF-alpha in experimental visceral leishmaniasis. Journal of immunology (Baltimore, Md. : 1950). 1994 Academic Article GET IT
Times cited: 117
Human immunodeficiency virus infection and bacteremic meningococcal pneumonia. The Journal of infectious diseases. 1991 Article GET IT
Times cited: 9